Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors.
Peptide display on solvent-exposed surfaces of engineered enzymes allows them to respond to anti-peptide antibodies by detectable changes in their enzymatic activity, offering a new principle for biosensor development. In this work, we show that multiple peptide insertion in the vicinity of the Escherichia coli beta-galactosidase active site dramatically increases the enzyme responsiveness to specific anti-peptide antibodies. The modified enzymes HD7872A and HT7278CA, carrying eight and 12 copies respectively of a foot-and-mouth disease peptide per enzyme molecule, show antibody-mediated activation factors higher than those previously observed in the first generation enzymatic sensors, for HT7278CA being close to 400%. The analysis of the signal transduction process with multiple inserted proteins strongly suggests a new, non-exclusive mechanism of enzymatic regulation in which the target proteins might be stabilised by the bound antibody, extending the enzyme half-life and consequently enhancing the signal-background ratio. In addition, the tested sensors are differently responsive to sera from immune farm animals, depending on the antigenic similarity between the B-cell epitopes in the immunising virus and those in the peptide used as sensing element on the enzyme surface. Altogether, these results point out the utility of these enzymatic biosensors for a simple diagnosis of foot-and-mouth disease in an extremely fast homogeneous assay.
Feliu
Jordi X
JX
Institut de Biotecnologia i de Biomedicina and Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, 08193, Barcelona, Spain.
Ferrer-Miralles
Neus
N
Blanco
Esther
E
Cazorla
Daniel
D
Sobrino
Francisco
F
Villaverde
Antonio
A
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D001665:Binding Sites; D001666:Binding Sites, Antibody; D015374:Biosensing Techniques; D002213:Capsid / Q000235:genetics / Q000276:immunology; D036022:Capsid Proteins; D002417:Cattle; D004789:Enzyme Activation; D004926:Escherichia coli / Q000378:metabolism; D005536:Foot-and-Mouth Disease / Q000175:diagnosis; D006207:Half-Life; D007114:Immunization; D008969:Molecular Sequence Data; D015202:Protein Engineering; D011994:Recombinant Proteins / Q000276:immunology; D015398:Signal Transduction; D013552:Swine; D001616:beta-Galactosidase / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral; D036022:Capsid Proteins; D011994:Recombinant Proteins; D001616:beta-Galactosidase